Schizophrenia is one of the most serious mental health disorders in the world. People living with schizophrenia may experience hallucinations, confused thinking, delusions, disorganized speech, and major difficulties in daily life.
For many patients, antipsychotic medicines can help reduce symptoms and improve stability. However, some people do not respond well to standard medications.
For these difficult cases, doctors often prescribe a medicine called clozapine. Clozapine is considered one of the most effective drugs for treatment-resistant schizophrenia, meaning it can help patients who do not improve with other antipsychotic medicines. Because of this, it is sometimes seen as a life-changing treatment.
But clozapine also comes with serious risks. Doctors have long known that the medicine can cause dangerous side effects, especially severe constipation, digestive problems, lung infections, and even life-threatening intestinal blockages. Until now, researchers have not fully understood why these problems happen.
Now, a new study from researchers at Chiba University in Japan may have found an important clue. The research, published in the journal Translational Psychiatry, suggests that clozapine may change the balance of microbes living in the gut and lungs.
These changes could help explain why some patients develop severe digestive and respiratory complications while taking the medication.
The study was led by researcher Kenji Hashimoto and his team at Chiba University. The scientists focused on the “gut-lung axis,” a growing area of research showing that the digestive system and lungs may influence each other through microbes, immune activity, and chemical signals inside the body.
The researchers became interested in this idea because doctors often see severe constipation and pneumonia appear together in patients taking clozapine. They wondered whether these problems might share the same biological cause.
To investigate this, the team carried out experiments using adult mice. Half of the mice received daily doses of clozapine for two weeks, while the other half received a placebo, which contained no active drug.
The researchers carefully monitored the animals’ body weight and digestive activity. They measured how much feces the mice produced to see whether the drug slowed down digestion. They also studied the microbes living inside the gut and lungs using advanced genetic analysis.
The results were striking. Mice treated with clozapine produced much less feces than the placebo group, showing that the drug slowed gastrointestinal movement. The mice also lost significant body weight during the study.
At the same time, the scientists found major changes in the microbial communities living in both the lungs and digestive system. The effects differed depending on the sex of the animals and the area of the body being examined.
The researchers then exposed the mice to lipopolysaccharide, a substance commonly used to trigger inflammation and simulate acute lung injury. Mice treated with clozapine showed greater vulnerability to lung damage and lower survival rates.
The study suggests that clozapine may create a chain reaction inside the body. By disrupting normal microbes in the gut and lungs, the drug may slow digestion, increase inflammation, alter metabolism, and weaken resistance to respiratory illness.
This finding could be important because pneumonia and intestinal blockage are among the most dangerous complications linked to clozapine treatment. In some cases, these side effects can become fatal.
The researchers believe their findings may help doctors develop safer ways to use clozapine in the future. Instead of stopping the medicine completely, doctors may eventually combine it with treatments designed to protect gut health and microbial balance.
For example, probiotics, special diets, or microbiome-based therapies could potentially reduce some of the medication’s harmful side effects. Scientists may also develop screening methods to identify patients at greater risk of complications before symptoms appear.
The research also highlights how closely connected the gut and lungs may be. Scientists increasingly believe that microbes living inside the body play major roles in immune function, metabolism, inflammation, and even brain health.
Although the study was performed in mice, the findings open new directions for human research. The researchers now plan to carry out long-term human studies to search for biomarkers linked to clozapine toxicity. They also hope to explore ways to monitor respiratory health and microbial changes during treatment.
The findings may eventually improve the safety of one of psychiatry’s most important medications. Clozapine remains a critical treatment option for people with severe schizophrenia who have few alternatives. Better understanding its side effects could help doctors protect patients while still providing the benefits of the drug.
The study also serves as another reminder that mental health medications can affect far more than the brain alone. Increasingly, scientists are discovering that the gut, lungs, immune system, and brain are deeply connected in ways researchers are only beginning to understand.
If you care about depression, please read studies that vegetarian diet may increase your depression risk, and Vitamin D could help reduce depression symptoms.
For more information about health, please see recent studies that ultra-processed foods may make you feel depressed, and these antioxidants could help reduce the risk of dementia.
Source: Chiba University.
